2`-5` oligoadenylate (2-5(A)) synthetase and protein kinase, RNA activated (PKR) are the only two known enzymes that bind double-stranded RNA (dsRNA) and get activated by it. We have previously identified their dsRNA binding domains, which do not have any sequence homology. Here, we report a profound difference between the two enzymes with respect to the structural features of the dsRNA that are required for their activation. The adenoviral virus-associated type I (VAI) RNA cannot activate PKR, although it binds to the protein and thereby prevents its activation by authentic dsRNA. In contrast, we observed that VAI RNA can both bind and activate 2-5(A) synthetase. Mutations in VAI RNA, which removed occasional mismatches present in its double-stranded stems, markedly enhanced its 2-5(A) synthetase-activating capacity. These mutants, however, are incapable of activating PKR. Other mutations, which disrupted the structure of the central stem-loop region of the VAI RNA, reduced its ability to activate 2-5(A) synthetase. These debilitated mutants could bind to the synthetase protein, although they fail to bind to PKR.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. J. Molinaro, B. K. Jha, K. Malathi, S. Varambally, A. M. Chinnaiyan, and R. H. Silverman Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells Nucleic Acids Res., December 2, 2006; 34(22): 6684 - 6695. [Abstract] [Full Text] [PDF]

				Y. Wang, S.-A. Xue, G. Hallden, J. Francis, M. Yuan, B. E. Griffin, and N. R. Lemoine Virus-Associated RNA I-Deleted Adenovirus, a Potential Oncolytic Agent Targeting EBV-Associated Tumors Cancer Res., February 15, 2005; 65(4): 1523 - 1531. [Abstract] [Full Text] [PDF]

				M. M. Whitmore, M. J. DeVeer, A. Edling, R. K. Oates, B. Simons, D. Lindner, and B. R. G. Williams Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity Cancer Res., August 15, 2004; 64(16): 5850 - 5860. [Abstract] [Full Text] [PDF]

				C. E. Samuel Antiviral Actions of Interferons Clin. Microbiol. Rev., October 1, 2001; 14(4): 778 - 809. [Abstract] [Full Text] [PDF]

				S. Goodbourn, L. Didcock, and R. E. Randall Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures J. Gen. Virol., October 1, 2000; 81(10): 2341 - 2364. [Full Text]

				A. Naganuma, A. Nozaki, T. Tanaka, K. Sugiyama, H. Takagi, M. Mori, K. Shimotohno, and N. Kato Activation of the Interferon-Inducible 2'-5'-Oligoadenylate Synthetase Gene by Hepatitis C Virus Core Protein J. Virol., September 15, 2000; 74(18): 8744 - 8750. [Abstract] [Full Text]

				S. N. Sarkar, S. Bandyopadhyay, A. Ghosh, and G. C. Sen Enzymatic Characteristics of Recombinant Medium Isozyme of 2'-5' Oligoadenylate Synthetase J. Biol. Chem., January 15, 1999; 274(3): 1848 - 1855. [Abstract] [Full Text] [PDF]

				M. Kumar and G. G. Carmichael Antisense RNA: Function and Fate of Duplex RNA in Cells of Higher Eukaryotes Microbiol. Mol. Biol. Rev., December 1, 1998; 62(4): 1415 - 1434. [Abstract] [Full Text] [PDF]

				R. Hartmann, P. L. Norby, P. M. Martensen, P. Jorgensen, M. C. James, C. Jacobsen, S. K. Moestrup, M. J. Clemens, and J. Justesen Activation of 2'-5' Oligoadenylate Synthetase by Single-stranded and Double-stranded RNA Aptamers J. Biol. Chem., February 6, 1998; 273(6): 3236 - 3246. [Abstract] [Full Text] [PDF]

				A. Ghosh, S. N. Sarkar, W. Guo, S. Bandyopadhyay, and G. C. Sen Enzymatic Activity of 2'-5'-Oligoadenylate Synthetase Is Impaired by Specific Mutations that Affect Oligomerization of the Protein J. Biol. Chem., December 26, 1997; 272(52): 33220 - 33226. [Abstract] [Full Text] [PDF]

				A. Ghosh, S. Y. Desai, S. N. Sarkar, P. Ramaraj, S. K. Ghosh, S. Bandyopadhyay, and G. C. Sen Effects of Mutating Specific Residues Present Near the Amino Terminus of 2'-5'-Oligoadenylate Synthetase J. Biol. Chem., June 13, 1997; 272(24): 15452 - 15458. [Abstract] [Full Text] [PDF]